Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
Guardado en:
Autores principales: | Mathieu Roumiguie, Alberto Contreras-Sanz, Gunjan Kumar, Peter C. Black |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4fb0060813c64bb1878148046dd05100 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
por: Ann Taber, et al.
Publicado: (2021) -
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Ann Taber, et al.
Publicado: (2020) -
Cisplatin is retained in the cochlea indefinitely following chemotherapy
por: Andrew M. Breglio, et al.
Publicado: (2017) -
A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma
por: Qi Zhong, et al.
Publicado: (2018) -
Clinical Impact of Molecular Subtyping of Pancreatic Cancer
por: Zhou Xu, et al.
Publicado: (2021)